Outcome of Chronic Subdural Hematoma Management With Double Burr Hole Craniotomy Versus Single Burr Hole Craniotomy and Subdural Drain Evacuation
1 other identifier
interventional
60
1 country
1
Brief Summary
The goal of this clinical trial is to compare the outcome of double burr hole versus single burr hole in patients of chronic subdural hematoma undergoing subdural drain evacuation. The main questions it aims to answers are 1\. Which one of the surgical method i.e single burr hole or double burr hole is clinically superior with better post operative prognosis for the drainage of chronic subdural hematoma. 2 Compare the post operative complications in both the techniques in term of wound infection hospital stay duration , recurrence and mortality. participants will be divided in two groups one group will be treated with single burr hole technique second group will be treated with double burr hole technique. After procedure, patients will be followed-up in hospital until discharge and total hospital stay will be noted. Patients will be followed-up further in OPD . During follow-up, patients will be evaluated for wound infection, recurrence and mortality.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 4, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 7, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 9, 2025
CompletedFirst Submitted
Initial submission to the registry
January 12, 2026
CompletedFirst Posted
Study publicly available on registry
January 26, 2026
CompletedJanuary 26, 2026
January 1, 2026
5 months
January 12, 2026
January 20, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Recurrence Of Chronic Subdural Hematoma
recurrence rate of chronic subdural hematoma evaluated if volume of sdh \>15ml or significant mass effect on CT brain within 3 months post operatively
From date of surgery until radiologically confirmed recurrence (defined as subdural hematoma volume >15 mL or significant mass effect on CT brain) requiring repeat intervention, assessed up to 3 months postoperatively
quantity of hematoma evacuated
Intraoperatively evacuated hematoma quantity measured in millilitres and also includes the quantity obtained in subdural drain till 72 hours postoperatively
Measured intraoperatively at the time of surgery and cumulatively measured postoperatively from surgery until removal of the subdural drain, assessed up to 72 hours postoperatively.
Study Arms (2)
Double burr Hole Arm
EXPERIMENTALthis arm includes patient who receive double burr hole craniotomy surgical procedure for drainage of chronic subdural hematoma
Single Burr Hole Arm
EXPERIMENTALthis arm includes patient who receive single burr hole craniotomy surgical procedure for drainage of chronic subdural hematoma
Interventions
Single Burr hole made at the point of highest collection of hematoma in subdural space in brain.
Two burr hole made in skull each at parietal eminence and around superior temporal line to drain chronic subdural hematoma
Eligibility Criteria
You may qualify if:
- Patients aged 20-70 years both genders diagnosed with subdural hematoma
You may not qualify if:
- Patients in shock (BP≤100/60 mmHg) or history of seizures
- Patients with bleeding disorder (PT\>15 sec) or intake of anti-coagulants
- Patients undergoing or already had ventriculoperitoneal shunt
- Patients with epilepsy, or obsessive compulsive decoder
- Patients with already operated for subdural hematoma
- Patients with post-cerebrospinal fluid diversion subdural hematoma
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Services Institute of Medical Sciences / Services Hospital
Lahore, Punjab Province, 54770, Pakistan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Muhammad Hassan Tabish, MBBS
Services Hospital / Services Institute of Medical Sciences
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Muhammad Hassan Tabish , MBBS, Neurosurgery Resident / Principal Investigator
Study Record Dates
First Submitted
January 12, 2026
First Posted
January 26, 2026
Study Start
October 4, 2024
Primary Completion
March 7, 2025
Study Completion
May 9, 2025
Last Updated
January 26, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share